Concordia Healthcare Corp (TSE:CXR)‘s stock had its “outperform” rating reissued by analysts at Royal Bank Of Canada in a report released on Tuesday. They currently have a C$35.00 price target on the stock. Royal Bank Of Canada’s price objective points to a potential upside of 198.13% from the stock’s previous close.
Other equities analysts have also issued reports about the stock. TD Securities lowered shares of Concordia Healthcare Corp from a “buy” rating to a “hold” rating and decreased their target price for the company from C$37.00 to C$20.00 in a report on Thursday, August 4th. Goldman Sachs Group Inc. decreased their target price on shares of Concordia Healthcare Corp from C$34.00 to C$17.00 in a report on Monday, August 15th. Finally, CIBC lowered shares of Concordia Healthcare Corp from a “sector perform” rating to an “underperform” rating in a report on Monday, August 15th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of C$54.33.
Concordia Healthcare Corp (TSE:CXR) traded down 2.30% during midday trading on Tuesday, hitting $11.47. 206,183 shares of the company were exchanged. The stock’s market capitalization is $585.17 million. The firm’s 50-day moving average price is $22.13 and its 200-day moving average price is $32.31. Concordia Healthcare Corp has a one year low of $10.85 and a one year high of $117.75.